Integration of woodchuck hepatitis and N‐myc rearrangement determine size and histologic grade of hepatic tumors

Integrations of woodchuck hepatitis virus (WHV) DNA and rearrangements of the N‐myc 2 gene have been detected frequently in hepatocellular carcinoma (HCC) of Eastern woodchucks (Marmota monax) chronically infected with WHV. Fifty‐five hepatocellular neoplasms and matched nontumor hepatic tissue specimens obtained postmortem from 13 chronic WHV carriers were analyzed and the frequency of WHV DNA integrations and of N‐myc rearrangements compared in tumors of different size and histologic grade. Four small tumor nodules were classified histologically as adenomas and integrated sequences of WHV DNA were detected in two of the four tumor nodules. In one of the two nodules, there was evidence of N‐myc rearrangement. Fifty‐one neoplasms were classified as HCC. Seven were grade 1 HCCs. WHV DNA integrations were demonstrated in 43% but none had N‐myc rearrangements. Twenty grade 2 HCCs had WHV DNA integrations in 80% and in 38% N‐myc rearrangements were present. Twenty‐four grade 3 HCCs had integrations of WHV DNA in 79% and N‐myc rearrangements in 74%. In two other grade 3 HCCs, rearrangements of N‐myc were detected in the absence of WHV DNA integrations. The 12 largest tumors in the series all were grade 2 or 3 HCCs, and in 83%, both WHV DNA integrations and N‐myc rearrangements were demonstrated. In conclusion, molecular changes observed in this study suggest a progression of genetic alterations providing either a significant proliferative stimulation and/or a growth advantage in hepatocarcinogenesis of woodchucks with chronic WHV infection. (HEPATOLOGY 2004;39:1008–1016.)

[1]  Chien-Jen Chen,et al.  Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.

[2]  J. Grisham Atlas of Tumor Pathology: Tumors of the Liver and Intrahepatic Bile Ducts , 2002 .

[3]  P. Schirmacher,et al.  Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis , 2001, British Journal of Cancer.

[4]  B. Pützer,et al.  Large nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes. , 2001, Journal of the National Cancer Institute.

[5]  B. Tennant Animal models of hepadnavirus-associated hepatocellular carcinoma. , 2001, Clinics in liver disease.

[6]  A. Kopp-Schneider,et al.  Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks. , 2000, Journal of hepatology.

[7]  K. Fung,et al.  Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA. , 2000, Life sciences.

[8]  G. Fourel,et al.  Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of β-catenin and synergistic effect of p53 null alleles , 2000, Oncogene.

[9]  B. Tennant,et al.  Treatment of chronic woodchuck hepatitis virus infection in the eastern woodchuck (marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans , 2000, Hepatology.

[10]  J. Prieto,et al.  Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: The woodchuck animal model , 2000, Cancer Gene Therapy.

[11]  M. Feitelson Hepatitis B virus in hepatocarcinogenesis , 1999, Journal of cellular physiology.

[12]  H. El‐Serag,et al.  Rising Incidence of Hepatocellular Carcinoma in the United States , 1999, Infection Control & Hospital Epidemiology.

[13]  G. Fourel,et al.  Woodchuck Hepatitis Virus Enhancer I and Enhancer II Are Both Involved in N-myc2 Activation in Woodchuck Liver Tumors , 1998, Journal of Virology.

[14]  J. Cullen,et al.  Lamivudine therapy of WHV-infected woodchucks. , 1998, Virology.

[15]  L Zhang,et al.  Antisense Downregulation of N-myc1 in Woodchuck Hepatoma Cells Reverses the Malignant Phenotype , 1998, Journal of Virology.

[16]  T. Uchiumi,et al.  A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. , 1997, Cancer research.

[17]  J. Jacob,et al.  Hepatic expression of the woodchuck hepatitis virus X‐antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X‐antigen antibody response , 1997, Hepatology.

[18]  F. Zoulim,et al.  Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatoma. , 1997, Journal of hepatology.

[19]  M. Buendia,et al.  The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice , 1997, Oncogene.

[20]  J. Jacob,et al.  Transformation of immortalized woodchuck hepatic cell lines with the c-Ha-ras proto-oncogene. , 1996, Carcinogenesis.

[21]  H. Prats,et al.  Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line. , 1995, Cancer research.

[22]  R. Lucito,et al.  The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. , 1995, The EMBO journal.

[23]  F. Chisari Hepatitis B virus transgenic mice: Insights into the virus and the disease , 1995, Hepatology.

[24]  T. Tango,et al.  Prospective study of chemoprevention of hepatocellular carcinoma with sho‐saiko‐to (TJ‐9) , 1995, Cancer.

[25]  J. Jacob,et al.  Woodchuck hepatitis virus surface antigen induces nitric oxide synthesis in hepatocytes: possible role in hepatocarcinogenesis. , 1994, Carcinogenesis.

[26]  C. Rogler,et al.  Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. , 1993, Cancer research.

[27]  D. Ganem,et al.  Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses , 1993, Molecular and cellular biology.

[28]  G. Fourel,et al.  Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter , 1992, Molecular and cellular biology.

[29]  G. Fourel,et al.  Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors , 1992, Journal of virology.

[30]  W. Caselmann,et al.  Hepatitis B virus transactivator MHBst: activation of NF‐kappa B, selective inhibition by antioxidants and integral membrane localization. , 1992, The EMBO journal.

[31]  M. Rossner Hepatitis B virus X‐gene product: A promiscuous transcriptional activator , 1992, Journal of medical virology.

[32]  C. Rogler,et al.  Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry. , 1991, Carcinogenesis.

[33]  Y. Dragan,et al.  Facts and theories concerning the mechanisms of carcinogenesis , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  H. Varmus,et al.  Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host , 1991, Journal of virology.

[35]  G. Fourel,et al.  Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours , 1990, Nature.

[36]  M. Buendia,et al.  Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma , 1988, Cell.

[37]  B. Tennant,et al.  Enzyme‐altered Liver Cell Foci in Woodchucks Infected with Woodchuck Hepatitis Virus , 1988, Japanese journal of cancer research : Gann.

[38]  J. Hoofnagle,et al.  Relation of the hepatitis B virus carrier state to hepatocellular carcinoma , 1987, Hepatology.

[39]  Mordecai Schwartz A biomathematical approach to clinical tumor growth , 1961, Cancer.

[40]  M. Roggendorf,et al.  Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus , 2005, Journal of Cancer Research and Clinical Oncology.

[41]  I. Toshkov,et al.  Mucin histochemistry of virus-induced duodenal adenomas in guinea fowl , 2005, Journal of Cancer Research and Clinical Oncology.

[42]  J. Bruix,et al.  Hepatitis B virus and hepatocellular carcinoma. , 2003, Journal of hepatology.

[43]  B. Tennant,et al.  The woodchuck model of hepatitis B virus infection. , 2001, ILAR journal.

[44]  H. Otto,et al.  “Slow-down” of the intrahepatic bile duct development between the 2nd and the 3rd trimester of gestation , 2000 .

[45]  F. X. Bosch,et al.  Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.

[46]  M. Makuuchi,et al.  Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events. , 1999, Scandinavian journal of gastroenterology.

[47]  W. Caselmann Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. , 1995, Journal of hepatology.

[48]  R. Koff Primary liver cancer: Etiological and progression factors , 1995 .

[49]  M. Buendia Hepatitis B viruses and hepatocellular carcinoma. , 1992, Advances in cancer research.

[50]  R. Novak,et al.  Use of the polymerase chain reaction for the sensitive detection of St. Louis encephalitis viral RNA. , 1992, Journal of virological methods.

[51]  M. Buendia,et al.  Evolutionary conservation of target sequences for cis-acting regulation in c-myc exon 1 and its upstream region. , 1990, Gene.

[52]  A. Zuckerman,et al.  Taxonomic classification of human hepatitis B virus. , 1986, Intervirology.

[53]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.